Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) has been given a consensus rating of “Buy” by the seven analysts that are covering the stock, Ratings reports. Seven research analysts have ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...

KEY and BNS complete the final tranche of equity investment in the former. This transaction will likely drive KeyCorp's NII ...

Several banks that boosted their capital bases this year saw their stock prices rise, a new analysis finds. The positive ...

The Bank of Nova Scotia (Scotiabank) has completed its purchase of KeyCorp’s common stock with an investment of approximately ...

KeyCorp has won approval from the U.S. Federal Reserve for a $2 billion investment from the Bank of Nova Scotia more rapidly than expected. KeyCorp KEY had expected the approval to come in the ...

The Bank of Nova Scotia (Scotiabank) has finalized its $2 billion investment in KeyCorp, acquiring approximately 14.9% of the ...

TORONTO — Bank of Nova Scotia says it has closed its two-part deal to buy a 14.9 per cent stake in U.S. bank KeyCorp for ...

Constellation Software was among the biggest drags on the Toronto market, falling 1.1% to C$4,497.31. Among mining stocks, B2Gold was 1.3% lower at C$3.54 and Hudbay Minerals lost 1.1% to C$11.74.

TORONTO - Scotiabank says it has closed its two-part deal to buy a 14.9 per cent stake in U.S. bank KeyCorp for about US$2.8 ...

KeyCorp  today announced that The Bank of Nova Scotia ("Scotiabank") has completed its purchase of KeyCorp's common stock with an investment of approximately $2.0 billion, as expected.  With this ...